TY - JOUR
T1 - [The concept and history of biomarker].
AU - Nonaka, Ryoji
AU - Nishimura, Junichi
AU - Mori, Masaki
PY - 2012/5
Y1 - 2012/5
N2 - Biomarker is a characteristic objectively measured and an indicator of biological process. This term indicates not only biological substance, for example protein, ribonucleic acid but also imaging assays. Disease biomarkers have been applied to a wide variety of clinical areas, including oncology, metabolic disorders, neurological disease and immune dysregulation. In recent years because of the progress of analysis technology, new biomarkers continue to be devised and used as diagnostic, predictive, prognostic, and toxic marker. In drug development area, biomarkers are used as surrogate endpoint to substitute for a clinical endpoint and needed for rational drug development. Here, we summarize the concept and history of biomarker.
AB - Biomarker is a characteristic objectively measured and an indicator of biological process. This term indicates not only biological substance, for example protein, ribonucleic acid but also imaging assays. Disease biomarkers have been applied to a wide variety of clinical areas, including oncology, metabolic disorders, neurological disease and immune dysregulation. In recent years because of the progress of analysis technology, new biomarkers continue to be devised and used as diagnostic, predictive, prognostic, and toxic marker. In drug development area, biomarkers are used as surrogate endpoint to substitute for a clinical endpoint and needed for rational drug development. Here, we summarize the concept and history of biomarker.
UR - http://www.scopus.com/inward/record.url?scp=84864505238&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84864505238&partnerID=8YFLogxK
M3 - Review article
C2 - 22619994
AN - SCOPUS:84864505238
SN - 0047-1852
VL - 70
SP - 737
EP - 742
JO - Nihon rinsho. Japanese journal of clinical medicine
JF - Nihon rinsho. Japanese journal of clinical medicine
IS - 5
ER -